Literature DB >> 18667134

Building cultural competency for improved diabetes care: Introduction and Overview.

William C Hsu1, Henry H Yoon, James R Gavin, Eugene Edward Wright, A Enrique Cabellero, Penny Tenzer.   

Abstract

Diabetes affects about 7% of the US population with more than 90% of cases being type 2 diabetes mellitus. In 2005, this translated into nearly 21 million Americans with diabetes. Whereas Americans from all ethnic and cultural groups are affected, minority populations are disproportionately affected. In fact, diabetes prevalence is 2 to 6 times higher among Latino Americans, African Americans, Native Americans (American Indians and Native Alaskans), and Asian Americans than among white Americans. The National Institutes of Health reports that American Indians and Native Alaskans are 2.2 times more likely to have the disease than are non-Hispanic whites. Furthermore, studies using glycosylated hemoglobin (A1C) as a marker have shown that Latino Americans, African Americans, and Asian Americans have poorer control of their diabetes. In a study by Brown and colleagues, mean A1C levels were higher among Latino Americans, African Americans, and Asian Americans/Pacific Islanders than among white Americans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18667134

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  3 in total

1.  Type 2 diabetes among Asian Americans: Prevalence and prevention.

Authors:  Tam H Nguyen; Thuc-Nhi Nguyen; Taylor Fischer; Won Ha; Thanh V Tran
Journal:  World J Diabetes       Date:  2015-05-15

2.  Racial and Ethnic Differences in Metabolic Disease in Adolescents With Obesity and Polycystic Ovary Syndrome.

Authors:  Stanley Andrisse; Yesenia Garcia-Reyes; Laura Pyle; Megan M Kelsey; Kristen J Nadeau; Melanie Cree-Green
Journal:  J Endocr Soc       Date:  2021-02-02

3.  Prescription cascading in developmentally disabled individuals.

Authors:  Isha Patel; Sarah Trinh; Thu Phan; Mark Johnson
Journal:  Indian J Pharmacol       Date:  2016 May-Jun       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.